Cargando…
Targeting cancer by binding iron: Dissecting cellular signaling pathways
Newer and more potent therapies are urgently needed to effectively treat advanced cancers that have developed resistance and metastasized. One such strategy is to target cancer cell iron metabolism, which is altered compared to normal cells and may facilitate their rapid proliferation. This is suppo...
Autores principales: | Lui, Goldie Y.L., Kovacevic, Zaklina, Richardson, Vera, Merlot, Angelica M., Kalinowski, Danuta S., Richardson, Des R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4662454/ https://www.ncbi.nlm.nih.gov/pubmed/26125440 |
Ejemplares similares
-
The proto-oncogene c-Src and its downstream signaling pathways are inhibited by the metastasis suppressor, NDRG1
por: Liu, Wensheng, et al.
Publicado: (2015) -
The molecular effect of metastasis suppressors on Src signaling and tumorigenesis: new therapeutic targets
por: Liu, Wensheng, et al.
Publicado: (2015) -
Unraveling the mysteries of serum albumin—more than just a serum protein
por: Merlot, Angelica M., et al.
Publicado: (2014) -
Potentiating the cellular targeting and anti-tumor activity of Dp44mT via binding to human serum albumin: two saturable mechanisms of Dp44mT uptake by cells
por: Merlot, Angelica M., et al.
Publicado: (2015) -
N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
por: Lane, Darius J. R., et al.
Publicado: (2013)